1. A Bayesian Stopping Rule for Sequential Monitoring of Serious Adverse Events. (July 2014) Authors: Kashiwabara, Kosuke; Matsuyama, Yutaka; Ohashi, Yasuo Journal: Therapeutic innovation & regulatory science Issue: Volume 48:Number 4(2014:Jul.) Page Start: 444 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A phase II study of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small-cell lung cancer in Japan (SAMURAI study). (February 2021) Authors: Tanzawa, Shigeru; Ushijima, Sunao; Shibata, Kazuhiko; Shibayama, Takuo; Bessho, Akihiro; Kaira, Kyoichi; Misumi, Toshihiro; Shiraishi, Kenshiro; Matsutani, Noriyuki; Tanaka, Hisashi; Inaba, Megumi; Haruyama, Terunobu; Nakamura, Junya; Kishikawa, Takayuki; Nakashima, Masanao; Iwasa, Keiichi; Fujiw... Journal: Therapeutic advances in medical oncology Issue: Volume 13(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Additional bevacizumab in EGFR-mutant lung adenocarcinoma patients who had oligo-progression after the failure of EGFR-TKI: A single-institute retrospective study. (2020) Authors: Kashiwabara, Kosuke; Fujii, Shinji; Tsumura, Shinsuke; Sakamoto, Kazuhiko; Semba, Hiroshi Journal: Cancer treatment and research communications Issue: Number 22(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Association of ABCB1 polymorphisms with erlotinib pharmacokinetics and toxicity in Japanese patients with non-small-cell lung cancer. (April 2012) Authors: Hamada, Akinobu; Sasaki, Ji-ichiro; Saeki, Sho; Iwamoto, Norihiro; Inaba, Megumi; Ushijima, Sunao; Urata, Maki; Kishi, Hiroto; Fujii, Shinji; Semba, Hiroshi; Kashiwabara, Kosuke; Tsubata, Yukari; Kai, Yuki; Isobe, Takeshi; Kohrogi, Hirotsugu; Saito, Hideyuki Journal: Pharmacogenomics Issue: Volume 13:Number 5(2012) Page Start: 615 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Association of ABCB1 polymorphisms with erlotinib pharmacokinetics and toxicity in Japanese patients with non-small-cell lung cancer. (April 2012) Authors: Hamada, Akinobu; Sasaki, Ji-ichiro; Saeki, Sho; Iwamoto, Norihiro; Inaba, Megumi; Ushijima, Sunao; Urata, Maki; Kishi, Hiroto; Fujii, Shinji; Semba, Hiroshi; Kashiwabara, Kosuke; Tsubata, Yukari; Kai, Yuki; Isobe, Takeshi; Kohrogi, Hirotsugu; Saito, Hideyuki Journal: Pharmacogenomics Issue: Volume 13:Number 5(2012) Page Start: 615 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Association of ABCB1 polymorphisms with erlotinib pharmacokinetics and toxicity in Japanese patients with non-small-cell lung cancer. (April 2012) Authors: Hamada, Akinobu; Sasaki, Ji-ichiro; Saeki, Sho; Iwamoto, Norihiro; Inaba, Megumi; Ushijima, Sunao; Urata, Maki; Kishi, Hiroto; Fujii, Shinji; Semba, Hiroshi; Kashiwabara, Kosuke; Tsubata, Yukari; Kai, Yuki; Isobe, Takeshi; Kohrogi, Hirotsugu; Saito, Hideyuki Journal: Pharmacogenomics Issue: Volume 13:Number 5(2012) Page Start: 615 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Chemotherapy should be performed in epidermal growth factor receptor mutation-positive lung adenocarcinoma patients who had progressive disease to the first epidermal growth factor receptor-tyrosine kinase inhibitor. Issue 9 (October 2020) Authors: Kashiwabara, Kosuke; Fujii, Shinji; Tsumura, Shinsuke; Sakamoto, Kazuhiko Journal: Anti-cancer drugs Issue: Volume 31:Issue 9(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Clinical impact of tumor location on the colon cancer survival and recurrence: analyses of pooled data from three large phase III randomized clinical trials. (25th September 2017) Authors: Aoyama, Toru; Kashiwabara, Kosuke; Oba, Koji; Honda, Michitaka; Sadahiro, Sotaro; Hamada, Chikuma; Maeda, Hiromichi; Mayanagi, Shuhei; Kanda, Mitsuro; Sakamoto, Junichi; Saji, Shigetoyo; Yoshikawa, Takaki Journal: Cancer medicine Issue: Volume 6:Number 11(2017:Nov.) Page Start: 2523 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Clinical Signatures of Mucinous and Poorly Differentiated Subtypes of Colorectal Adenocarcinomas by a Propensity Score Analysis of an Independent Patient Database from Three Phase III Trials. Issue 4 (April 2018) Authors: Kanda, Mitsuro; Oba, Koji; Aoyama, Toru; Kashiwabara, Kosuke; Mayanagi, Shuhei; Maeda, Hiromichi; Honda, Michitaka; Hamada, Chikuma; Sadahiro, Sotaro; Sakamoto, Junichi; Saji, Shigetoyo; Yoshikawa, Takaki Journal: Diseases of the colon & rectum Issue: Volume 61:Issue 4(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Clinical utility of Todai OncoPanel in the setting of approved comprehensive cancer genomic profiling tests in Japan. Issue 4 (17th January 2023) Authors: Kage, Hidenori; Shinozaki‐Ushiku, Aya; Ishigaki, Kazunaga; Sato, Yusuke; Tanabe, Masahiko; Tanaka, Shota; Tanikawa, Michihiro; Watanabe, Kousuke; Kato, Shingo; Akagi, Kiwamu; Uchino, Keita; Mitani, Kinuko; Takahashi, Shunji; Miura, Yuji; Ikeda, Sadakatsu; Kojima, Yasushi; Watanabe, Kiyotaka; Moch... Journal: Cancer science Issue: Volume 114:Issue 4(2023) Page Start: 1710 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗